Urology Doctors in Ogden, UT Accepting Medicare

6 Urology doctors found. Showing 1 - 6

Dr. Curtis M Campbell, MD Urology Medicare: Medicare Enrolled Practice Location: 4403 Harrison Blvd, Suite 4400, Ogden, UT 84403 Phone: 801-387-4550    Fax: 801-387-4565

Dr. John S Wolthuis, MD Urology Medicare: Not Enrolled in Medicare Practice Location: 4700 Harrison Blvd, Ogden, UT 84403 Phone: 801-475-3000    Fax: 801-475-3001

Brian W Heaton Sr., MD PC Urology Medicare: Accepting Medicare Assignments Practice Location: 4403 Harrison Blvd, Suite 4400, Ogden, UT 84403 Phone: 801-387-4550    Fax: 801-387-4565

Robert O Wayment, MD Urology Medicare: Accepting Medicare Assignments Practice Location: 4700 Harrison Blvd, Ogden, UT 84403 Phone: 801-475-3160    Fax: 801-475-3161

Bradford Jason Stevenson, MD Urology Medicare: Accepting Medicare Assignments Practice Location: 4700 Harrison Blvd, Ogden, UT 84403 Phone: 801-475-3160    Fax: 801-475-3161

Tyler L Christensen, MD Urology Medicare: Accepting Medicare Assignments Practice Location: 4700 Harrison Blvd, Ogden, UT 84403 Phone: 801-475-3160    Fax: 801-475-3161

News Archive

Pre-clinical studies of ID-12 orally-bioavailable inhibitor completes

ChemDiv Inc. of San Diego, and iDialog (Intellektualniy Dialog) of Yaroslavl, Russia, announced today the successful completion of a pre-clinical development and the subsequent nomination of ID-12 as lead clinical development candidate for the treatment of chronic hepatitis C. This novel small molecule orally-bioavailable inhibitor of hepatitis C virus (HCV) blocks early stage of viral infection.

Women show a better response to lung cancer therapy, resulting in better survival rates

However, in untreated patients, women also had a 21 percent decreased risk of death as compared with men, leading researchers to believe lung cancer in women has a different biologic behavior and natural history than in men.

Transplanted insulin-producing cells survive better when the activation of NKT cells are blocked

Scientists in Japan have found a way to improve on a promising diabetes treatment. In the October 3 issue of The Journal of Experimental Medicine, Masaru Taniguchi and colleagues report that transplanted insulin-producing cells survive better when the activation of a specific type of immune cell is blocked.

CDRH report highlights scientific activities that support medical device industry

The U.S. Food and Drug Administration's Center for Devices and Radiological Health (CDRH) today released a report highlighting scientific activities that support the medical device industry and product development, while maintaining the safety and effectiveness of the products.

FDA clears Sotera Wireless' patented continuous non-invasive blood pressure technology

Sotera Wireless, Inc. today announced the U.S. Food and Drug Administration has cleared the Company's patented continuous non-invasive blood pressure technology, a new feature of the ViSi Mobile wireless patient monitoring system. For the first time clinicians can continuously monitor all patient vital signs, including beat-to-beat blood pressure, without the use of a catheter or blood pressure cuff.

Read more Medical News

› Verified 7 days ago